Apoptosis enhancing nuclease Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-87017
Key Product Details
Species Reactivity
Validated:
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Summary for Apoptosis enhancing nuclease Antibody
Immunogen
The immunogen is a synthetic peptide directed towards the N-terminal region of human Apoptosis enhancing nuclease. Peptide sequence: REAPESAQCLCPSLTIPNAKDVLRKRHKRRSRQHQRFMARKALLQEQGLL The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for Apoptosis enhancing nuclease Antibody
Western Blot: Apoptosis enhancing nuclease Antibody [NBP2-87017]
Western Blot: Apoptosis enhancing nuclease Antibody [NBP2-87017] - Host: Rabbit. Target Name: AEN. Sample Tissue: Human MCF7 Whole Cell lysates. Antibody Dilution: 1ug/mlApplications for Apoptosis enhancing nuclease Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Apoptosis enhancing nuclease
Alternate Names
apoptosis enhancing nuclease, EC 3.1, EC 3.1.13.1, FLJ12484, FLJ12562, interferon stimulated exonuclease gene 20kDa-like 1, Interferon-stimulated 20 kDa exonuclease-like 1, ISG20L1apoptosis-enhancing nuclease, pp12744
Gene Symbol
AEN
Additional Apoptosis enhancing nuclease Products
Product Documents for Apoptosis enhancing nuclease Antibody
Product Specific Notices for Apoptosis enhancing nuclease Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...